Evidence map›Paper›PMID 18199803›Full record

ArticleJournal of the American Society of Nephrology : JASN2008

tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis.

Kebin Hu, Ling Lin, Xiaoyue Tan, Junwei Yang, Guojun Bu, Wendy M Mars, Youhua Liu

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. p90RSK modulates inter-and intracellular signaling in kidney diseases.Frontiers in cell and developmental biology · 2025
    Review
  5. Matrix metalloproteinases in kidney homeostasis and diseases: an update.American journal of physiology. Renal physiology · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Cell Cycle Dysregulation and Renal Fibrosis.Frontiers in cell and developmental biology · 2021
    Review
  15. Article
  16. Review
  17. Mitochondrial Protection by PARP Inhibition.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Kebin HuDepartment of Pathology, University of Pittsburgh, S-405 Biomedical Science Tower, 200 Lothrop Street, Pittsburgh, PA 15261, USA.
Ling Lin
Xiaoyue Tan
Junwei Yang
Guojun Bu
Wendy M Mars
Youhua Liu
University of Pittsburgh · USNanjing Medical University · CNWashington University in St. Louis · US

Funding

Tenancin-C as a major component of the fibrogenic nicheR01DK064005 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TAN, RODERICK JASON · 2003 to 2021
$5.1M
HGF Gene Therapy for Chronic Renal FibrosisR01DK061408 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LIU, YOUHUA · 2002 to 2009
$1.9M
Integrin-linked Kinase and Renal Interstitial FibrosisR01DK071040 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LIU, YOUHUA · 2005 to 2008
$1.0M
NIDDK NIH HHS DK061408NIDDK NIH HHS DK064005NIDDK NIH HHS DK071040NIDDK NIH HHS R01 DK061408NIDDK NIH HHS R01 DK064005NIDDK NIH HHS R01 DK071040
6 · The paper itself

Abstract

Activation and expansion of interstitial fibroblasts and myofibroblasts play an essential role in the evolution of renal fibrosis. After obstructive injury, mice lacking tissue-type plasminogen activator (tPA) have fewer myofibroblasts and less interstitial fibrosis than wild-type controls. This suggests that tPA controls the size of the fibroblast/myofibroblast population in vivo, and this study sought to determine the underlying mechanism. In vitro, tPA inhibited staurosporine or H(2)O(2)-induced caspase-3 activation, prevented cellular DNA fragmentation, and suppressed the release of cytochrome C from mitochondria into the cytosol in a rat interstitial fibroblast cell line (NRK-49F). tPA also protected TGF-beta1-activated myofibroblasts from apoptosis. This antiapoptotic effect of tPA was independent of its protease activity but required its membrane receptor, the LDL receptor-related protein 1 (LRP-1). Deletion or knockdown of LRP-1 abolished tPA-mediated cell survival, whereas re-introduction of an LRP-1 minigene in a mouse LRP-1-deficient fibroblast cell line (PEA-13) restored the cytoprotective ability of tPA. tPA triggered a cascade of survival signaling involving extracellular signal-regulated kinase 1/2 (Erk1/2), p90RSK, and phosphorylation of Bad. Blockade of Erk1/2 activation abrogated the antiapoptotic effect of tPA, whereas expression of constitutively active MEK1 promoted cell survival similar to tPA. In vivo, compared with wild-type controls, apoptosis of interstitial myofibroblasts was increased in tPA(-/-) mice after obstructive injury, and myofibroblasts were completely depleted 4 wk after relief of the obstruction. Together, these findings illustrate that tPA is a survival factor that prevents apoptosis of renal interstitial fibroblasts and myofibroblasts through an LRP-1-, Erk1/2-, p90RSK-, and Bad-dependent mechanism.

Indexed as

AnimalsApoptosisbcl-Associated Death ProteinExtracellular Signal-Regulated MAP KinasesFibroblastsHydrogen PeroxideKidneyLow Density Lipoprotein Receptor-Related Protein-1MAP Kinase Signaling SystemMiceMice, KnockoutOxidative StressPhosphorylationReceptors, LDLRibosomal Protein S6 Kinases, 90-kDaStaurosporinebcl-Associated Death ProteinExtracellular Signal-Regulated MAP KinasesHydrogen PeroxideLow Density Lipoprotein Receptor-Related Protein-1Lrp1 protein, mouseReceptors, LDLRibosomal Protein S6 Kinases, 90-kDaStaurosporineTissue Plasminogen ActivatorTumor Suppressor Proteins

Identifiers

PMID18199803
PMCPMC2391054
OpenAlexW2132642214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.